Collegium to Present Pediatric and Real-World Research Across ADHD Portfolio at AACAP and NEI Fall Congresses

Collegium Pharmaceutical announced that seven abstracts from its ADHD portfolio were accepted for presentation at the AACAP 2026 Annual Meeting (Oct 26-31, Atlanta) and the NEI Fall Congress (Nov 5-8, Colorado Springs). The presentations include Phase 4 studies of AZSTARYS in pediatric populations and real-world analyses of JORNAY PM in adults, plus caregiver survey research; the real-world analyses are described as observational and hypothesis-generating.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.